1. Normal gastrointestinal tract inflammatory cells and review of select benign hematolymphoid proliferations
- Author
-
Jennifer Y. Ju, Edward B. Stelow, and Elizabeth L Courville
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,Inflammatory bowel disease ,Lymphoid hyperplasia ,Pathology and Forensic Medicine ,Diagnosis, Differential ,03 medical and health sciences ,0302 clinical medicine ,Microscopic colitis ,medicine ,Humans ,Gastrointestinal tract ,Hyperplasia ,business.industry ,Stomach ,Lymphoma, B-Cell, Marginal Zone ,medicine.disease ,Lymphoma ,Gastrointestinal Tract ,030104 developmental biology ,Lymphatic system ,030220 oncology & carcinogenesis ,Primary immunodeficiency ,medicine.symptom ,business - Abstract
The luminal gastrointestinal tract can be a site of robust immune response in which reactive lymphoproliferative processes can sometimes be difficult to distinguish from lymphoma. In this article, we review gastrointestinal tract normal resident inflammatory cells and common nonneoplastic lymphoproliferative responses with emphasis on their differential and links to lymphoma. Topics that are covered include lymphocytic esophagitis, gastric chronic inflammation, mucosa-associated lymphoid tissue, and ulceration, small intestinal lymphoid hyperplasia, celiac disease, microscopic colitis, inflammatory bowel disease, primary immunodeficiency, graft-versus-host disease, and anti-programmed cell death protein-1 effect. We additionally present the less common differential of histiocytic processes within the gastrointestinal tract. The aim of this paper is to serve as a reference for practicing pathologists facing lymphoid, lymphoplasmacytic, or histiocytic processes in the luminal gastrointestinal tract. We hope to help the practicing pathologist distinguish benign from malignant entities and identify features requiring further workup.
- Published
- 2021
- Full Text
- View/download PDF